MainosMemos contains the latest research and information about eye and vision care of children, developmental disabilities, Traumatic/Acquired Brain Injury and other topics of interest to me (and hopefully you!).
The authors performed a randomized, placebo-controlled trial in children with persistent amblyopia using levodopa in addition to patching. Children aged 7 to 12 years who had undergone patching therapy for amblyopia received either levodopa or a placebo in addition to the patching. After 18 weeks of combined treatment, there was no significant difference in improvement of visual acuity between the placebo and patching groups.
In this trial, levodopa did not appear to be an effective adjunct to patching in children with residual amblyopia."
– Kathy Freeman, OD, FAAO
Comments: We need to use all the tools available to us when treating children with amblyopia. Will there be an "amblyopia pill" that we can use in the future? At the moment the use of Levodopa has mixed results. DM